Related references
Note: Only part of the references are listed.Ezetimibe: an update on its clinical usefulness in specific patient groups
Daniel Hammersley et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2017)
Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses
Gulsum E. Muku et al.
LABORATORY INVESTIGATION (2017)
Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/CD36 Pathway to Promote Hepatic Steatosis in Mice
Liu Yao et al.
HEPATOLOGY (2016)
Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression
Nathaniel G. Girer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1
Benjamin J. Moyer et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Epidemiology of coronary heart disease and acute coronary syndrome
Fabian Sanchis-Gomar et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure
C-X Xu et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
The controversy of a wider statin utilization: why?
Ishak Mansi et al.
EXPERT OPINION ON DRUG SAFETY (2013)
TCDD-Elicited Effects on Liver, Serum, and Adipose Lipid Composition in C57BL/6 Mice
Michelle Manente Angrish et al.
TOXICOLOGICAL SCIENCES (2013)
Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver
Rance Nault et al.
TOXICOLOGY LETTERS (2013)
The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression
Timothy V. Beischlag et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner
Rachel Tanos et al.
HEPATOLOGY (2012)
Induction of Intracellular Calcium Concentration by Environmental Benzo(a)pyrene Involves a β2-Adrenergic Receptor/Adenylyl Cyclase/Epac-1/Inositol 1,4,5-Trisphosphate Pathway in Endothelial Cells
Abdullah Mayati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Role of the Ah Receptor in Homeostatic Control of Fatty Acid Synthesis in the Liver
Rachel Tanos et al.
TOXICOLOGICAL SCIENCES (2012)
Integration of Genome-Wide Computation DRE Search, AhR ChIP-chip and Gene Expression Analyses of TCDD-Elicited Responses in the Mouse Liver
Edward Dere et al.
BMC GENOMICS (2011)
Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men
Andre J. Tremblay et al.
JOURNAL OF LIPID RESEARCH (2011)
Suppression of Cytokine-Mediated Complement Factor Gene Expression through Selective Activation of the Ah Receptor with 3′,4′-Dimethoxy-α-naphthoflavone
Iain A. Murray et al.
MOLECULAR PHARMACOLOGY (2011)
Identification of aryl hydrocarbon receptor binding targets in mouse hepatic tissue treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin
Raymond Lo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Development of a Selective Modulator of Aryl Hydrocarbon (Ah) Receptor Activity that Exhibits Anti-Inflammatory Properties
Iain A. Murray et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Jung Hoon Lee et al.
GASTROENTEROLOGY (2010)
HNF1α and SREBP2 are important regulators of NPC1L1 in human liver
Camilla Pramfalk et al.
JOURNAL OF LIPID RESEARCH (2010)
Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression
Dan Feng et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions
Fumiaki Ohtake et al.
BIOCHEMICAL PHARMACOLOGY (2009)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL
Michael S. Brown et al.
JOURNAL OF LIPID RESEARCH (2009)
Ah receptor represses acute-phase response gene expression without binding to its cognate response element
Rushang D. Patel et al.
LABORATORY INVESTIGATION (2009)
Ezetimibe blocks internalization of the NPC1L1/cholesterol complex
Ta-Yuan Chang et al.
CELL METABOLISM (2008)
The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1
Liang Ge et al.
CELL METABOLISM (2008)
Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver
Shoko Sato et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients
Livia Pisciotta et al.
ATHEROSCLEROSIS (2007)
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetirnibe
Ryan E. Temel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Zetia: Inhibition of Niemann-Pick C1 like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia
Harry R. Davis et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2007)
Dioxin receptor is a ligand-dependent E3 ubiquitin ligase
Fumiaki Ohtake et al.
NATURE (2007)
Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: role of sterol regulatory element binding protein 2
Waddah A. Alrefai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Aryl hydrocarbon receptor-and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a] pyrene
Monique N'Diaye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Genetic defenses against noncholesterol sterols
EL Klett et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Inhibition of intestinal cholesterol absorption by ezetimibe in humans
T Sudhop et al.
CIRCULATION (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Statins: mechanism of action and effects
C Stancu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2001)
Cholesterol absorption efficiency and sterol metabolism in obesity
TA Miettinen et al.
ATHEROSCLEROSIS (2000)
Non-carcinogenic effects of TCDD in animals
LS Birnbaum et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2000)
Share Paper
